RayKnowChina Research Map
Shortlist

RecruitingCongenital heart diseaseN/A

Registered title, quoted from ClinicalTrials.gov

Multicenter Randomized Controlled Trial (RCT) and Efficacy Evaluation System Study on Surgical Innovation Strategies for Neonatal Complex Congenital Heart Disease

An open trial on congenital heart disease, registered on ClinicalTrials.gov. Led by Central China Fuwai Hospital; 11 other hospitals on this site are listed as study sites.

Status, phase and start date as registered on ClinicalTrials.gov on 18 Nov 2026; the registry may have changed since. Whether someone can take part is decided by the study team. Not medical advice.

The study team’s contact details are on the registry record. This site does not pass on enquiries.

Hospitals in mainland China listed for this trial 12

Hospitals on this site that the registry record names as lead sponsor or study site, where the site is open. Lead sponsor first, then study sites A–Z.

  1. Lead sponsorCentral China Fuwai HospitalZhengzhouHospital page
  2. Study siteChildren's Hospital of Chongqing Medical University重庆医科大学附属儿童医院ChongqingHospital page
  3. Study siteChildren's Hospital of Nanjing Medical University南京市儿童医院NanjingHospital page
  4. Study siteChildren's Hospital, Zhejiang University School of Medicine浙江大学医学院附属儿童医院HangzhouHospital page
  5. Study siteFuwai Hospital中国医学科学院阜外心血管病医院BeijingHospital page
  6. Study siteGuangzhou Women and Children's Medical Center广州市妇女儿童医疗中心GuangzhouHospital page
  7. Study siteQingdao Women and Children's Hospital青岛市妇女儿童医院QingdaoHospital page
  8. Study siteSecond Xiangya Hospital中南大学湘雅二医院ChangshaHospital page
  9. Study siteShanghai Children's Medical Center上海交通大学医学院附属上海儿童医学中心ShanghaiHospital page
  10. Study siteUnion Hospital华中科技大学同济医学院附属协和医院WuhanHospital page
  11. Study siteWest China Second University Hospital四川大学华西第二医院ChengduHospital page
  12. Study siteXijing Hospital空军军医大学西京医院Xi'anHospital page

The record may name more sites, including outside mainland China, and sites can open or close during a trial. Full list of sites on ClinicalTrials.gov

Source: ClinicalTrials.gov record NCT07363538, read on 18 Nov 2026; hospital names matched to this site’s hospital list. How names are matched

Checklist for this trial 1

Only the points this trial’s record answers definitely: the registered age and sex, and criteria lines that state a number, score, stage or named test, quoted word for word. Tick a point once it has been compared with the medical records.

Show the checklist (1 points)Hide the checklist
  1. Not stated to 7 days; sex: all

    Registered eligibility fields

Ticks stay on this page; they are not saved or sent. Meeting every point is not enough: the study team decides after its own screening. Lines that need the team’s judgement, such as “sufficient organ function”, are not in this list; they are in the full criteria below. Not stated definitely in this record: diagnosis and how it was confirmed; stage or severity, as the trial defines it; earlier treatment; day-to-day activity level; blood tests: counts, liver and kidney function; scans and measurable lesions; other conditions the trial excludes; pregnancy, breastfeeding and contraception.

Questions to ask the study team

Picked from the record by fixed keyword rules (not by AI, not checked by hand) and quoted from ClinicalTrials.gov, NCT07363538, read on 10 Nov 2026.

Registered criteria

Quoted as registered on ClinicalTrials.gov, in English, read on 10 Nov 2026. This site has not checked, shortened or translated them. Meeting the written criteria is not enough: the study team decides after its own screening.

Inclusion Criteria:

  • Neonates diagnosed with TAPVC, CoA/IAA, TGA, PA/IVS, or severe PS via pre-admission cardiac echocardiography;
  • Patients and families demonstrating high compliance, willing to sign informed consent forms and agree to complete one year of follow-up and related examinations.

Exclusion Criteria:

  • Preterm infant (gestational age < 36 weeks at birth);
  • Low birth weight (weight < 2.5 kg);
  • Concurrent severe extracardiac anomalies or complex cardiac malformations;
  • Preoperative respiratory or circulatory instability requiring emergency surgery.

Quoted from ClinicalTrials.gov, NCT07363538, participation criteria. Read on 10 Nov 2026.

Where this information comes from

The registry record

ClinicalTrials.gov (US National Library of Medicine), record NCT07363538, read on 18 Nov 2026. A trial has a page here while its overall status is recruiting, not yet recruiting or enrolling by invitation and at least one listed hospital’s site is open. Trials registered only in China’s own registry (ChiCTR) are not included.

Diseases and hospitals

The trial is listed under a disease when this site’s ClinicalTrials.gov search for that disease in China returns it. Sponsor and site names in the record are matched to this site’s hospital list (ROR identifiers, checked aliases). Definitions

What is left out

Names of investigators and contact persons in the record, and anything not in the record. The title and criteria are quoted from the record.

Suggest a correctionClinicalTrials.gov NCT07363538